دورية أكاديمية
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands.
العنوان: | Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. |
---|---|
المؤلفون: | Slot E; Department of Blood-borne Infections, Sanquin Research, Amsterdam, The Netherlands. e.slot@sanquin.nl.; Department of Medical Affairs, Sanquin Corporate Staff, Amsterdam, The Netherlands. e.slot@sanquin.nl., Hogema BM; Department of Blood-borne Infections, Sanquin Research, Amsterdam, The Netherlands.; Department of Virology, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Reusken CBEM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands., Reimerink JH; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Molier M; Department of Blood-borne Infections, Sanquin Research, Amsterdam, The Netherlands., Karregat JHM; Department of Donor Studies, Sanquin Research, Amsterdam, The Netherlands., IJlst J; National Screening Laboratory, Sanquin Laboratory Services, Amsterdam, The Netherlands., Novotný VMJ; Department of Medical Affairs, Sanquin Blood Bank, Amsterdam, The Netherlands., van Lier RAW; Landsteiner Laboratory, Sanquin Research, Amsterdam, The Netherlands.; Department of Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands., Zaaijer HL; Department of Blood-borne Infections, Sanquin Research, Amsterdam, The Netherlands. h.zaaijer@sanquin.nl.; Department of Virology, Sanquin Diagnostic Services, Amsterdam, The Netherlands. h.zaaijer@sanquin.nl.; Department of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands. h.zaaijer@sanquin.nl. |
المصدر: | Nature communications [Nat Commun] 2020 Nov 12; Vol. 11 (1), pp. 5744. Date of Electronic Publication: 2020 Nov 12. |
نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [London] : Nature Pub. Group |
مواضيع طبية MeSH: | Antibodies, Viral/*blood , Blood Donors/*statistics & numerical data , Coronavirus Infections/*epidemiology , Pneumonia, Viral/*epidemiology, Adolescent ; Adult ; Aged ; Asymptomatic Diseases/epidemiology ; Betacoronavirus/isolation & purification ; COVID-19 ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Middle Aged ; Netherlands ; Pandemics ; Prevalence ; SARS-CoV-2 ; Seroepidemiologic Studies ; Social Isolation ; Young Adult |
مستخلص: | The world is combating an ongoing COVID-19 pandemic with health-care systems, society and economies impacted in an unprecedented way. It is unclear how many people have contracted the causative coronavirus (SARS-CoV-2) unknowingly and are asymptomatic. Therefore, reported COVID-19 cases do not reflect the true scale of outbreak. Here we present the prevalence and distribution of antibodies to SARS-CoV-2 in a healthy adult population of the Netherlands, which is a highly affected country, using a high-performance immunoassay. Our results indicate that one month into the outbreak (i) the seroprevalence in the Netherlands was 2.7% with substantial regional variation, (ii) the hardest-hit areas showed a seroprevalence of up to 9.5%, (iii) the seroprevalence was sex-independent throughout age groups (18-72 years), and (iv) antibodies were significantly more often present in younger people (18-30 years). Our study provides vital information on the extent of exposure to SARS-CoV-2 in a country where social distancing is in place. |
References: | N Engl J Med. 2020 Mar 26;382(13):1194-1196. (PMID: 32074416) Nature. 2020 Apr;580(7803):316-318. (PMID: 32242115) Nature. 2020 Mar 23;:. (PMID: 32205872) Immunity. 2020 May 19;52(5):737-741. (PMID: 32433946) J Med Virol. 2020 Oct;92(10):1902-1914. (PMID: 32293716) JAMA. 2020 May 12;323(18):1824-1836. (PMID: 32282022) J Clin Med. 2020 Mar 31;9(4):. (PMID: 32244365) Nature. 2020 Mar;579(7798):265-269. (PMID: 32015508) Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. (PMID: 32221519) Clin Infect Dis. 2011 Apr 1;52(7):911-6. (PMID: 21427399) Ann Intern Med. 2020 Sep 15;173(6):450-460. (PMID: 32496919) Nat Med. 2020 Jul;26(7):1033-1036. (PMID: 32398876) Int J Infect Dis. 2020 Jun;95:311-315. (PMID: 32234343) Lancet. 2020 Aug 1;396(10247):313-319. (PMID: 32534626) Nat Med. 2020 Aug;26(8):1193-1195. (PMID: 32504052) JAMA Intern Med. 2020 Oct 1;180(10):1356-1362. (PMID: 32808970) Eur Psychiatry. 2020 Apr 01;63(1):e32. (PMID: 32234102) Virus Res. 2014 Dec 19;194:175-83. (PMID: 24670324) Epidemiol Infect. 1990 Oct;105(2):435-46. (PMID: 2170159) Science. 2020 May 1;368(6490):489-493. (PMID: 32179701) Lancet. 2020 Jun 20;395(10241):e110-e111. (PMID: 32534627) Euro Surveill. 2020 Apr;25(14):. (PMID: 32290905) Lancet Infect Dis. 2020 Apr;20(4):398-400. (PMID: 32113510) BMJ. 2020 Apr 2;369:m1375. (PMID: 32241884) Nat Med. 2020 May;26(5):643-644. (PMID: 32405055) Lancet. 2020 Apr 4;395(10230):1101-1102. (PMID: 32247384) Nat Rev Immunol. 2020 Aug;20(8):457-458. (PMID: 32636479) Int J Biol Sci. 2020 Mar 15;16(10):1678-1685. (PMID: 32226285) J Med Virol. 2020 Sep;92(9):1380-1382. (PMID: 32281679) Ann Intern Med. 2020 May 05;172(9):577-582. (PMID: 32150748) Emerg Infect Dis. 2020 Jul;26(7):1478-1488. (PMID: 32267220) Cell Host Microbe. 2020 Jun 10;27(6):976-991.e11. (PMID: 32320678) J Clin Virol. 2020 Jul;128:104437. (PMID: 32434708) Nat Commun. 2020 Sep 17;11(1):4704. (PMID: 32943637) Science. 2020 Jun 5;368(6495):1060-1061. (PMID: 32414781) Int J Mol Sci. 2020 Apr 10;21(7):. (PMID: 32290293) JAMA. 2020 Apr 28;323(16):1561-1562. (PMID: 32219429) |
المشرفين على المادة: | 0 (Antibodies, Viral) 0 (Immunoglobulin G) 0 (Immunoglobulin M) |
تواريخ الأحداث: | Date Created: 20201113 Date Completed: 20201124 Latest Revision: 20231112 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC7665189 |
DOI: | 10.1038/s41467-020-19481-7 |
PMID: | 33184284 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!